IP Library Granted Patent US 9,725,743
Granted Patent B2
US 9,725,743 · App. 13/732,887 · Granted Aug 8, 2017

Metabolically engineered cells for the production of pinosylvin

Inventors: Michael Katz (Malmo, SE); Jochen Forster (Copenhagen, DK); Helga David (Copenhagen, DK); Hans Peter Schmidt (Holte, DK); Malin Sendelius (Lund, SE); Sara Peterson Bjorn (Lyngby, DK); Thomas Thomasen Durhuus (Copenhagen, DK)
Assignee: Evolva SA
C12P7/22C12N9/1029C12N9/88C12N9/93
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,725,743
App. No.
13/732,887
Granted
Aug 8, 2017
Kind
B2
Abstract

A genetically engineered micro-organism having an operative metabolic pathway producing cinnamoyl-CoA and producing pinosylvin therefrom by the action of a stilbene synthase is used for pinosylvin production. Said cinnamic acid may be formed from L-phenylalanine by a L-phenylalanine ammonia lyase (PAL) which is one accepting phenylalanine as a substrate and producing cinammic acid therefrom, preferably such that if the PAL also accepts tyrosine as a substrate and forms coumaric acid therefrom, the ratio Km(phenylalanine)/Km(tyrosine) for said PAL is less than 1:1 and if said micro-organism produces a cinammate-4 -hydroxylase enzyme (C4H), the ratio K cat (PAL)/K cat (C4H) is at least 2:1.

Claims (16)

1. A recombinant microorganism comprising an operative metabolic pathway for producing pinosylvin, wherein said recombinant microorganism comprises:

a) a L-phenylalanine ammonia lyase (PAL) from Arabidopsis thaliana , for converting L-phenylalanine to cinnamic acid;

b) a 4-coumarate-CoA ligase from Arabidopsis thaliana , for converting cinnamic acid to cinnamoyl-CoA; and

c) a stilbene synthase from Vitis vinifera , for converting cinnamoyl-CoA to pinosylvin,

wherein said microorganism is Saccharomyces cerevisiae and produces at least 1.5 mg/g pinosylvin on a dry weight basis.

2. The recombinant microorganism of claim 1 , comprising:

a) one or more copies of a heterologous nucleotide sequence encoding said L-phenylalanine ammonia lyase operatively linked with an expression signal not natively linked with the said L-phenylalanine ammonia lyase,

b) one or more copies of a heterologous nucleotide sequence encoding said 4-coumarate CoA-ligase operatively linked with an expression signal not natively linked with said 4-coumarate CoA-ligase, and

c) one or more copies of a heterologous nucleotide sequence encoding said stilbene synthase operatively linked with an expression signal not natively linked with said stilbene synthase.

3. A method for producing pinosylvin comprising culturing said recombinant microorganism of claim 1 under conditions to produce said pinosylvin.

4. The recombinant microorganism of claim 1 , wherein said L-phenylalanine ammonia lyase is expressed in said recombinant microorganism from a nucleotide sequence encoding the amino acid sequence of SEQ ID NO: 2.

5. The recombinant microorganism of claim 1 , wherein said 4-coumarate-CoA ligase is expressed in said recombinant microorganism from a nucleotide sequence encoding the amino acid sequence of SEQ ID NO: 4.

6. The recombinant microorganism of claim 1 , wherein said stilbene synthase is expressed in said recombinant microorganism from a nucleotide sequence encoding the amino acid sequence of SEQ ID NO: 10.

7. The recombinant micro-organism of claim 2 , wherein said expression signal not natively linked with said L-phenylalanine ammonia lyase, said 4-coumarate CoA-ligase or said stilbene synthase is a constitutive promoter.

8. The recombinant microorganism of claim 1 , wherein said recombinant microorganism produces pinosylvin directly from glucose, without addition of cinnamic acid, cinnamoyl-CoA or any other downstream cinnamic acid derivative.

9. The recombinant microorganism of claim 1 , wherein said recombinant microorganism produces at least 1.8 mg/g pinosylvin on a dry weight basis

Assignments (1)
MERGER Recorded Jun 27, 2024
From: EVOLVA SA
To: DANSTAR FERMENT AG
Reel/Frame 067863/0857 →
Priority Claims (1)
GB 0614442.2 · Jul 20, 2006 · national
Continuity (2)
Continuation 12374659
Related Publication 20140024862A1 · Jan 23, 2014